NO810758L - Fremgangsmaate for oekning av den orale absorpsjon av beta-lactamantibiotika - Google Patents

Fremgangsmaate for oekning av den orale absorpsjon av beta-lactamantibiotika

Info

Publication number
NO810758L
NO810758L NO810758A NO810758A NO810758L NO 810758 L NO810758 L NO 810758L NO 810758 A NO810758 A NO 810758A NO 810758 A NO810758 A NO 810758A NO 810758 L NO810758 L NO 810758L
Authority
NO
Norway
Prior art keywords
beta
oral absorption
increasing
lactamantibiotics
procedure
Prior art date
Application number
NO810758A
Other languages
English (en)
Other versions
NO159767C (no
NO159767B (no
Inventor
Takeru Higuchi
Toshiaki Nishihata
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of NO810758L publication Critical patent/NO810758L/no
Publication of NO159767B publication Critical patent/NO159767B/no
Publication of NO159767C publication Critical patent/NO159767C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO810758A 1980-03-07 1981-03-05 Anvendelse av et hjelpestoff som tilsetning til beta-laktamantibiotikum for aa oeke absorpsjonsgraden av antibiotikumet i blodet ved oral administrering. NO159767C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12809980A 1980-03-07 1980-03-07

Publications (3)

Publication Number Publication Date
NO810758L true NO810758L (no) 1981-09-08
NO159767B NO159767B (no) 1988-10-31
NO159767C NO159767C (no) 1989-02-08

Family

ID=22433628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810758A NO159767C (no) 1980-03-07 1981-03-05 Anvendelse av et hjelpestoff som tilsetning til beta-laktamantibiotikum for aa oeke absorpsjonsgraden av antibiotikumet i blodet ved oral administrering.

Country Status (11)

Country Link
EP (1) EP0036534B1 (no)
JP (1) JPS56128714A (no)
AT (1) ATE29837T1 (no)
DE (1) DE3176461D1 (no)
DK (1) DK101981A (no)
ES (1) ES500184A0 (no)
FI (1) FI810637L (no)
GR (1) GR74441B (no)
IE (1) IE52973B1 (no)
NO (1) NO159767C (no)
PT (1) PT72616B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541247B2 (en) * 1979-12-20 1985-01-03 R.P. Scherer Corporation Adjuvants for rectal delivery of drug substances
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JPH05248655A (ja) * 1992-01-09 1993-09-24 Daikin Ind Ltd 空気調和装置
DE69321285T2 (de) * 1992-05-15 1999-03-04 Shiseido Co Ltd Äusserliches Hautpräparat
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
WO1998026803A1 (fr) * 1996-12-19 1998-06-25 Daiichi Pharmaceutical Co., Ltd. Composition pharmaceutique pour administration par voie orale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1036194A (en) * 1962-03-26 1966-07-13 William Kurt Wallersteiner Improvements relating to antibiotic compositions
US3676434A (en) * 1970-07-29 1972-07-11 Lilly Co Eli Cephalosporin salts
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Also Published As

Publication number Publication date
JPS6346727B2 (no) 1988-09-19
NO159767C (no) 1989-02-08
IE810452L (en) 1981-09-07
NO159767B (no) 1988-10-31
ES8301107A1 (es) 1982-12-01
EP0036534B1 (en) 1987-09-23
ES500184A0 (es) 1982-12-01
GR74441B (no) 1984-06-28
EP0036534A1 (en) 1981-09-30
PT72616B (en) 1985-10-04
JPS56128714A (en) 1981-10-08
FI810637L (fi) 1981-09-08
DE3176461D1 (en) 1987-10-29
PT72616A (en) 1981-04-01
DK101981A (da) 1981-09-08
ATE29837T1 (de) 1987-10-15
IE52973B1 (en) 1988-04-27

Similar Documents

Publication Publication Date Title
AU556734B2 (en) Oral absorption of polar bioactive agents
NO810758L (no) Fremgangsmaate for oekning av den orale absorpsjon av beta-lactamantibiotika
EP0041047A3 (de) Dioxidverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
SE8500965D0 (sv) Mellanprodukter for framstellning av beta-laktamasinhibitorer
AU545885B2 (en) Oral absorption of glycosidic antibiotics
ATE9584T1 (de) Antibakterielle beta-lactam-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FI884911A0 (fi) Laekemedel, i dessa saosom aktiva aemnen befintliga fosforin innehaollande 2-isoxazoliner och isoxazoler samt foerfarande foer framstaellning av dessa heterocykliska foereningar.
SE8009049L (sv) 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
FI830192A0 (fi) Foerfarande foer framstaellning av penicillinderivat
IT1141970B (it) Antibiotico inibitore della beta-lattamesi e procedimento per la sua produzione